Application of the phosphoramidate protide approach to the antiviral drug ribavirin

Derudas, Marco, McGuigan, Christopher ORCID: https://orcid.org/0000-0001-8409-710X, Brancale, Andrea ORCID: https://orcid.org/0000-0002-9728-3419, Neyts, J. and Balzarini, J. 2008. Application of the phosphoramidate protide approach to the antiviral drug ribavirin. Antiviral Research 78 (2) , 55. 10.1016/j.antiviral.2008.01.115

Full text not available from this repository.

Abstract

Ribavirin is a nucleoside analogue with antiviral activity against a number of DNA and RNA viruses in vitro and in vivo (Sidwell et al., 1972). Ribavirin has been approved for the treatment of respiratory syncytial virus and for the treatment of hepatitis C virus in association with interferon. The bioactivation of ribavirin involves intracellular phosphorylation to its 5′-monophosphate mediated by adenosine kinase followed by further phosphorylation to the di- and tri-phosphate. Its broad spectrum of antiviral activity prompted us to design and synthesise a new series of ribavirin phosphoramidates in order to investigate its activity against different viruses. The synthesis and the biological evaluation for these compounds will be reported.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Pharmacy Systems Immunity Research Institute (SIURI)
Publisher:	Elsevier
ISSN:	0166-3542
Last Modified:	05 Jan 2024 05:55
URI:	https://orca.cardiff.ac.uk/id/eprint/6493

Citation Data

Actions (repository staff only)

Edit Item